Novo Nordisk A/S has announced the launch of its acclaimed obesity drug, Wegovy, in China, a strategic move aimed at tapping into the world’s second-largest economy’s burgeoning weight-loss market. The drug, known for its impact on body weight management, will be available at a remarkably lower price compared to its cost in the United States, […]
Tag: obesity
Back To Top
